Stay updated with breaking news from Eric Rubin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Novavax’s shot would be the fourth Covid vaccine authorized for use in the U.S. The shots use different technology than Pfizer and Moderna.
WASHINGTON, United States -- A panel of experts convened by the US drug regulator on Tuesday recommended the Novavax Covid-19 shot, a late runner in the fight against the virus that could nonetheless play a role in overcoming vaccine hesitancy. (FILES) This file photo illustration picture shows v
A panel of independent vaccine experts recommended Tuesday that the Food and Drug Administration authorize a vaccine developed by Novavax, paving the way for the fourth coronavirus shot in the United States.
The Food and Drug Administration advisory committee has recommended the agency give the green light to Novavax’s Covid-19 vaccine, which offers a more traditional, non-mRNA alternative to the Pfizer and
Novavax'sCovid vaccine received a unanimous recommendation for adults aged 18 years and older from a panel of independent experts at the Food and Drug Administration.